Moderna and MSD have initiated a Phase III clinical study to evaluate mRNA-4157 (V940), an investigational individualised ...

The Celtics sale is being watched closely. Not just to see if it reaches a record number, but for what it could mean for the ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that Canada's Drug Agency (CDA) has ...

Financial writer reviews Gildan Activewear Inc.'s stock growth and valuation metrics, questioning if potential growth is ...

The Love Better campaign is a primary prevention initiative, aiming to equip young New Zealanders with the tools to navigate ...

COPENHAGEN, Denmark, October 31, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in ...

AstraZeneca’s presence in South Africa has become a driving force in global health research, contributing significantly to respiratory, cardiovascular, and oncology therapeutic areas. The ...

The Government has very conveniently cherry-picked data from the latest MSD projections to justify its cruel agenda and punch ...

COPENHAGEN, Denmark, October 31, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology powered vaccines, provides business up ...

Sharad Kelkar is known for his versatile acting, seamlessly slipping into any role he plays. However, this time, his fans seem to have already picked his next character. After sharing his new ...

Building on the legacy of Brera FC, which it acquired in 2022, the Company aims to create opportunities for tournament prizes ...